A detailed history of Virtus ETF Advisers LLC transactions in Insmed Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 5,344 shares of INSM stock, worth $405,502. This represents 0.19% of its overall portfolio holdings.

Number of Shares
5,344
Previous 5,344 -0.0%
Holding current value
$405,502
Previous $358,000 8.94%
% of portfolio
0.19%
Previous 0.18%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$22.0 - $69.71 $172,678 - $547,153
-7,849 Reduced 59.49%
5,344 $358,000
Q1 2024

May 15, 2024

BUY
$25.72 - $29.94 $48,816 - $56,826
1,898 Added 16.8%
13,193 $357,000
Q4 2023

Feb 15, 2024

SELL
$23.42 - $31.74 $104,968 - $142,258
-4,482 Reduced 28.41%
11,295 $350,000
Q3 2023

Nov 07, 2023

SELL
$19.86 - $26.93 $40,454 - $54,856
-2,037 Reduced 11.43%
15,777 $398,000
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $39,587 - $50,808
2,408 Added 15.63%
17,814 $375,000
Q1 2023

May 15, 2023

BUY
$16.26 - $21.73 $4,406 - $5,888
271 Added 1.79%
15,406 $262,000
Q4 2022

Feb 14, 2023

BUY
$16.98 - $23.15 $27,066 - $36,901
1,594 Added 11.77%
15,135 $302,000
Q3 2022

Nov 14, 2022

BUY
$20.88 - $28.21 $4,113 - $5,557
197 Added 1.48%
13,541 $292,000
Q2 2022

Aug 12, 2022

SELL
$17.07 - $25.71 $8,961 - $13,497
-525 Reduced 3.79%
13,344 $263,000
Q4 2021

Feb 14, 2022

SELL
$25.89 - $33.45 $36,038 - $46,562
-1,392 Reduced 9.12%
13,869 $378,000
Q3 2021

Nov 15, 2021

SELL
$22.46 - $29.47 $31,421 - $41,228
-1,399 Reduced 8.4%
15,261 $420,000
Q2 2021

Aug 10, 2021

BUY
$24.17 - $36.01 $23,734 - $35,361
982 Added 6.26%
16,660 $474,000
Q1 2021

May 17, 2021

BUY
$32.28 - $44.3 $13,751 - $18,871
426 Added 2.79%
15,678 $534,000
Q4 2020

Feb 12, 2021

SELL
$31.45 - $40.54 $196,373 - $253,131
-6,244 Reduced 29.05%
15,252 $508,000
Q3 2020

Nov 13, 2020

BUY
$26.0 - $34.5 $47,086 - $62,479
1,811 Added 9.2%
21,496 $691,000
Q2 2020

Aug 05, 2020

SELL
$14.11 - $29.42 $80,003 - $166,811
-5,670 Reduced 22.36%
19,685 $542,000
Q1 2020

May 14, 2020

SELL
$13.63 - $33.98 $29,154 - $72,683
-2,139 Reduced 7.78%
25,355 $406,000
Q4 2019

Feb 13, 2020

BUY
$16.12 - $24.98 $272,186 - $421,787
16,885 Added 159.16%
27,494 $657,000
Q3 2019

Nov 12, 2019

SELL
$15.49 - $25.78 $9,154 - $15,235
-591 Reduced 5.28%
10,609 $187,000
Q2 2019

Aug 13, 2019

BUY
$23.0 - $32.19 $257,600 - $360,528
11,200 New
11,200 $287,000
Q1 2019

May 14, 2019

SELL
$13.91 - $31.15 $286,629 - $641,876
-20,606 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$11.6 - $18.7 $44,718 - $72,088
3,855 Added 23.01%
20,606 $270,000
Q3 2018

Nov 14, 2018

SELL
$18.95 - $28.08 $226,774 - $336,033
-11,967 Reduced 41.67%
16,751 $339,000
Q2 2018

Aug 10, 2018

BUY
$20.0 - $29.72 $86,180 - $128,063
4,309 Added 17.65%
28,718 $679,000
Q1 2018

May 14, 2018

BUY
$21.69 - $32.99 $280,126 - $426,065
12,915 Added 112.36%
24,409 $550,000
Q4 2017

Feb 14, 2018

SELL
$26.43 - $31.78 $245,904 - $295,681
-9,304 Reduced 44.74%
11,494 $358,000
Q3 2017

Nov 14, 2017

BUY
$11.61 - $31.21 $22,082 - $59,361
1,902 Added 10.07%
20,798 $649,000
Q2 2017

Aug 14, 2017

BUY
N/A
18,896
18,896 $324,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10.3B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.